BTC stays above $95K as ETF weekly outflows weigh on momentum. Nevertheless, November sees record inflows, boosting ...
Improved outlook for the DeFi space and warmer regulatory climate with incoming U.S. administration are main drivers behind ...
US exchange-traded funds investing directly in Bitcoin and Ether are enjoying unprecedented demand, buoyed by President-elect ...
Grayscale Investments has seen its cryptocurrency holdings skyrocket in November, driven by surging altcoins like Stellar ...
We recently published an article titled Jim Cramer Thinks These 13 Stocks Will Benefit From the New Administration. In this ...
Daily Maverick on MSN6h
The bitcoin revolution: why skepticism fades as global leaders embrace a new reserve assetAfter much laughter and derision, followed by years of vicious state pushback, bitcoin seems to have won the day, if not the century (if not the future). It’s no longer speculative or risky. It is ...
Bitcoin exchange-traded funds have been such a smashing success in the US that they now hold more than 1 million of the ...
Cryptopolitan on MSN10h
Pump.fun loses 66% of its revenue following livestream controversySolana meme coin launchpad pump.fun has lost some of its weekly revenue. According to data from DefiLlama, the platform has ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
Strategic-beta ETPs continue to see healthy net flows with a stable market share relative to the total ETP market. In recent years, the strategic-beta ETP market has shown remarkable growth and ...
For the first time in 30 years, a drug used to treat endometriosis will be listed on the pharmaceutical benefits scheme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback